| Award Year |
Recipient |
Presentation |
|
2021
|
Shaymaa Hegazy (1st place) |
DNA mismatch repair deficient non-neoplastic endometrial glands are common in Lynch syndrome patients and present at higher density compared to colorectal mucosa
|
|
2021
|
Simon Roy (2nd place) |
HPV-independent, p53 independent non-invasive verruciform lesions of the vulva: a comparison of clinical, histological and recurrence parameters
|
|
2021
|
Lawrence Hsy Lin (2nd place) |
Small tumor nests are associated with poor clinical outcome in clear cell carcinoma of ovary
|
|
2022
|
Felix Kommoss (1st place) |
Methylation Analysis Supports Classification of Endometrial Stromal Sarcomas with Variant BCOR and BCORL1 Alterations as High-Grade Endometrial Stromal Sarcomas
|
|
2022
|
Janira Navarro (2nd place) |
Utility of a Comprehensive NGS 523-Gene Panel for the Simultaneous Analysis of Homologous Recombination Deficiency Score and Percent Genomic Loss of Heterozygosity Using a Cytogenetic Software Applied to the Evaluation of Epithelial Ovarian Tumors
|
|
2022
|
Darin Dolezal (3rd place) |
Progressive microsatellite instability in recurrent MSI-H endometrial adenocarcinomas coincides with ARID1A frameshift and CTNNB1 mutations
|
|
2023
|
Phoebe Hammer (1st place, shared) |
TCGA Molecular Subgroup Shows Greater Prognostic Significance Than Histologic Diagnosis in High-Grade Endometrial Carcinomas with Spindled, Undifferentiated and
Sarcomatous Components
|
|
2023
|
Neslihan Kayraklioglu (1st place, shared) |
High Tumor Mutational Burden Predicts Recurrence in Copy
Number Low Early-Stage Endometrial Cancer and is Associated with ARID1A and TP53 Mutations
|
|
2023
|
Xiaoming Zhang (2nd place) |
High-Grade Transformation of Ovarian Serous Borderline
Tumors: A Series and Literature Review
|